EXTREME REVERSE TRANSKRIPTIONS PCR

European patent · EP3337615 · In force

Register entry

Publication number
EP3337615
Application number
EP16863087
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Nov 4, 2016
Published
Jun 27, 2018
Granted
Feb 16, 2022
Protection ends at the latest
Nov 3, 2036
Next annual fee due
Nov 30, 2026
IPC classes
C12Q 1/686 (2018.01)
Priority
US 201562251400 P 05.11.2015
PCT application
PCT/US2016/060650 04.11.2016
PCT publication
WO2017/079636 11.05.2017
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Dec 1, 2025

    Change

    Published in Swissreg on 01.12.2025

  2. Dec 1, 2024

    Change

    Published in Swissreg on 01.12.2024

  3. Dec 1, 2023

    Change

    Published in Swissreg on 01.12.2023

  4. May 9, 2023

    Address changed

    Representative
    Valipat S.A., c/o BOVARD SA Neuchâtel, Rue des Noyers 11, 2000 Neuchâtel → VALIPAT, c/o BOVARD LTD, Optingenstrasse 16, 3013 Bern

    Published in Swissreg on 09.05.2023

  5. Dec 28, 2022

    Change

    Published in Swissreg on 28.12.2022

  6. Dec 6, 2022

    Change

    Published in Swissreg on 06.12.2022

  7. Jun 24, 2022

    Agent entered

    Representative
    Valipat S.A., c/o BOVARD SA Neuchâtel, Rue des Noyers 11, 2000 Neuchâtel

    Published in Swissreg on 24.06.2022

  8. Feb 16, 2022

    Granted

    Published in Swissreg on 16.02.2022

Parties

Inventor

WITTWER, Carl T.

Salt Lake City, Utah 84109, US

HOUSKEEPER, Jessica Anne

Wellington, Utah 84542, US

QUACKENBUSH, John Francis

Salt Lake City, Utah 84104, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.